Patients and sample collection
The present study was approved by the Ethics Committee of Renmin Hospital of Wuhan University (Wuhan, China), and verbal and written informed consent was obtained from all patients prior to participation. All methods were performed in accordance with the relevant guidelines and regulations. A total of 23 patients who underwent gynecological surgery in our hospital were selected from March 2020 to December 2021, which including 10 patients with SUI (with anterior vaginal wall prolapse or cystocele, POP-Q Ⅲ ~ Ⅳ: Ba > + 1, as SUI group), and the other 13 patients underwent total hysterectomy for benign tumors (control group). During the operation, the tissue specimens (0.5*0.5*0.5cm3) were obtained from the anterior vaginal wall, and then sent to the laboratory within half an hour for follow-up experiment. There was no evidence of connective tissue disease, endometriosis, or gynecologic malignancy in any of the recruited patients. We excluded patients who had undergone surgery in the anterior vaginal wall site or applied estrogen within the past three months.
Primary cell culture
We cultured and purified hAVWFs according to our previous description [11]. Briefly, the anterior vaginal wall tissues were cut into pieces (approximately 1 mm3), placed in culture bottles and digested with Type I Collagenase (ThermoFisher, catalog No. 17100-017) and trypsinase (Servicebio, catalog No. G4001). The fibroblasts were grown in serum-free DMEM (HyClone, catalog No. SH30243) supplemented with 20% fetal bovine serum (HyClone, catalog No. SV30087), and 100 U/ml penicillin/streptomycin (Beyotime, catalog No. ST488) at 37 °C in an incubator with 5% CO2. Following passage at 85% confluency, hAVMFs were used for subsequent experiments at passages 3 to 6. For the latrunculin A (Lat-A, a potent inhibitor of F-actin assembly; Cayman, catalog No. 10010630) experiment, hAVMFs were treated with Lat-A (0.5 μM) for 24 h.
Immunohistochemistry (IHC)
The paraffin-embedded human anterior vaginal wall samples were cut into 4μm-thick sections, which were then dewaxed with xylene and rehydrated. Incubation with anti-Piezo1 (Affinit, 1:200, catalog No. DF12083) overnight at 4°C followed by secondary antibody (Maxim Biotechnologies, Fuzhou, China) incubation for 1 hour at room temperature was carried out after antigen repair using microwave or citrate antigen retrieval solutions. The DAB kit (Maxim Biotechnologies, Fuzhou, China) was used as the chromogenic agent, and hematoxylin was used for nuclei counterstaining. Dehydration and sealing were performed in sequence, and the positive expression quantification was performed using ImageJ 1.48r software.
Mechanical stretching application
As previously described[12], the mechanical stretching loaded on hAVMFs was generated by a four‑point bending device (SXG4201; Chengdu Miracle Chemicals Co., Ltd., Chengdu, China). Basically, there were three parts to the device: strain plates, dishes, and a drive control. The parameters of mechanical force were set to 2666 με(the loading displacement was 4 mm) as the magnitude of the force on the sample and a frequency of 0.1 Hz for 4 h.
Phalloidin staining
After different treatments, Fluor-phalloidin (CST, catalog no. 8953) was incubated at room temperature for 1 h after hAVWFs had been fixed with 4% fresh paraformaldehyde for 15 minutes and permeabilized with 0.4% Triton X-100 for 5 minutes. Nuclei were stained with DAPI and observed under a fluorescence microscope. Quantitative analyses of indicated stains were performed using ImageJ software.
Flow cytometry
The apoptosis of hAVWFs in different groups were detected by flow cytometry. A total of 100 liters of binding buffer were used to resuspend hAVWFs after digestion with trypsinase and washing with PBS three times. Afterwards, for each group, 5 μL of PE Annexin V and 7μL of 7-AAD were added in accordance with the instructions on the PE Annexin V Apoptosis Detection Kit I (BD Biosciences, catalog No. 559763, USA). Apoptosis was detected by flow cytometry after gently resuspending the hAVWFs and incubating them for 15 minutes at room temperature in the dark.
Small interfering RNA
We transiently transfected primary hAVWFs with siRNA (Piezo1-targeting siRNA) using transfection reagent (GeneChem Co., Ltd., Shanghai, China) according to the manufacturer’s instructions. In order to assess knockdown efficiency, Western blots were used to detect changes in the expression of each protein.
Immunofluorescence
The morphology of hAVWFs was characterized as spindle-shaped and they were identified by Immunocytochemistry staining which showed a positive staining for vimentin and negative staining for cytokeratin. Cells from passages 3-6 of hAVWFs were cultured in chamber slides to 50% confluency. As previously described[13], after fixation with 4% paraformaldehyde and cell membrane permeabilization with Triton X100, hAVWFs were incubated overnight with anti-Piezo1 (Affinit, 1:200, catalog No. DF12083), anti-vimentin (Santa, catalog No. sc-6260; 200 μg/ml) and anti-cytokeratin (Santa, catalog No. sc-376224, 200 μg/ml) at 4 °C. Nuclei were stained with DAPI and observed under a fluorescence microscope. Quantitative analyses of indicated stains were performed using ImageJ software.
Western blotting
After exposure to different treatments, a proteinase inhibitor was added to RIPA lysis buffer, enabling the total proteins of hAVWFs to be isolated. Samples were used to evaluate protein quantification with a BCA assay kit (Beyotime Institute of Biotechnology, catalog No. P0010, Haimen, China). In total, 20 g of total protein were separated by SDS-PAGE then transferred to a polyvinylidene fluoride membrane (PVDF, Merck KGaA) using 10% SDS-PAGE, followed by blocking with 5% nonfat milk-TBST (TBS with 0.1% Tween 20) and incubation with the rabbit primary antibodies purchased from Affinity Biosciences and Abcam: anti-Piezo1 (1:1,000, catalog No. DF12083) and anti-GAPDH (1:2,000, catalog No. ab9485, served as an internal reference control) overnight at 4˚C. Then, the membranes were incubated with relevant HRP-conjugated secondary antibody for 1 h at room temperature. The reactive bands were exposed using 500 μL Western Lightning Plus-ECL (Perkin Elmer; catalog No. NEL105001EA) on a ChemiDoc MP Imaging System (Bio-Rad). Each sample's band density was normalized against the density of GAPDH, and data were obtained from three experiments.
Statistical analysis
Significant differences between groups were evaluated using the GraphPad Prism 6 (GraphPad Prism INC, CA, USA) program using one-way ANOVA (more than two groups) followed by a Tukey’s posttest for multiple comparisons within tested groups. Student’s t test was used to compare two groups. The differences were considered significant with P < 0.05.